User login
Research Awards Program
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
What the election results mean for GI
In the Senate, Democrats clinched the majority with 50 seats. Only one race, Georgia, is still undecided where a December runoff is planned. This race will not flip the majority since Vice President Kamala Harris casts tie-breaking votes as the President of the Senate.
Republicans recaptured control of the House after reaching 218 seats – enough to take control but the sweeping flip “red wave” did not occur as predicted. Republicans currently hold 220 seats to 213 Democratic seats, while two seats remain undecided. Margins in both chambers are slim, reflecting the division in the country.
What does this mean?
The majorities in both chambers are razor thin and compromises will need to be made to pass funding bills and other priorities.
AGA will continue to prioritize our bipartisan efforts with congressional champions on both sides of the aisle, including Rep. Ami Bera (D-Calif.), Rep. Larry Bucshon (R-Ind.), Sen. Sherrod Brown (D-Ohio), and Sen. Bill Cassidy (R-La.). For the remainder of this Congress, we will fight to:
- Encourage the Senate to take a vote on the House-passed prior authorization reform bill.
- Support robust federal research funding for gastroenterology.
- Reduce dangerous cuts in the Medicare Physician Fee Schedule, effective Jan. 1, 2023.
In the Senate, Democrats clinched the majority with 50 seats. Only one race, Georgia, is still undecided where a December runoff is planned. This race will not flip the majority since Vice President Kamala Harris casts tie-breaking votes as the President of the Senate.
Republicans recaptured control of the House after reaching 218 seats – enough to take control but the sweeping flip “red wave” did not occur as predicted. Republicans currently hold 220 seats to 213 Democratic seats, while two seats remain undecided. Margins in both chambers are slim, reflecting the division in the country.
What does this mean?
The majorities in both chambers are razor thin and compromises will need to be made to pass funding bills and other priorities.
AGA will continue to prioritize our bipartisan efforts with congressional champions on both sides of the aisle, including Rep. Ami Bera (D-Calif.), Rep. Larry Bucshon (R-Ind.), Sen. Sherrod Brown (D-Ohio), and Sen. Bill Cassidy (R-La.). For the remainder of this Congress, we will fight to:
- Encourage the Senate to take a vote on the House-passed prior authorization reform bill.
- Support robust federal research funding for gastroenterology.
- Reduce dangerous cuts in the Medicare Physician Fee Schedule, effective Jan. 1, 2023.
In the Senate, Democrats clinched the majority with 50 seats. Only one race, Georgia, is still undecided where a December runoff is planned. This race will not flip the majority since Vice President Kamala Harris casts tie-breaking votes as the President of the Senate.
Republicans recaptured control of the House after reaching 218 seats – enough to take control but the sweeping flip “red wave” did not occur as predicted. Republicans currently hold 220 seats to 213 Democratic seats, while two seats remain undecided. Margins in both chambers are slim, reflecting the division in the country.
What does this mean?
The majorities in both chambers are razor thin and compromises will need to be made to pass funding bills and other priorities.
AGA will continue to prioritize our bipartisan efforts with congressional champions on both sides of the aisle, including Rep. Ami Bera (D-Calif.), Rep. Larry Bucshon (R-Ind.), Sen. Sherrod Brown (D-Ohio), and Sen. Bill Cassidy (R-La.). For the remainder of this Congress, we will fight to:
- Encourage the Senate to take a vote on the House-passed prior authorization reform bill.
- Support robust federal research funding for gastroenterology.
- Reduce dangerous cuts in the Medicare Physician Fee Schedule, effective Jan. 1, 2023.
AGA makes its first investment through new GI innovation fund
Virgo provides gastroenterologists, clinical trial sponsors, and trial site investigators with artificial intelligence–fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with inflammatory bowel disease clinical trials.
Virgo provides gastroenterologists, clinical trial sponsors, and trial site investigators with artificial intelligence–fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with inflammatory bowel disease clinical trials.
Virgo provides gastroenterologists, clinical trial sponsors, and trial site investigators with artificial intelligence–fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with inflammatory bowel disease clinical trials.
Joint society task force releases strategic plan on climate change
Key takeaway: As a procedure-intense subspecialty, gastroenterology, and in particular endoscopy, is a major contributor to health care’s carbon footprint and other environmental impacts. Endoscopy is the third largest generator of medical waste in a hospital (2 kg total waste per procedure) with most ending in landfills. With this strategic plan, the participating societies are committed to promoting and supporting a sustainable, high-quality GI practice.
The U.S. GI multisociety strategic plan, which has also been endorsed by 23 GI societies globally, is a collaborative effort that invites members to undertake initiatives to establish an environmentally sustainable, high-quality practice and promote planetary health. Each society will prioritize and adapt their initiatives in accordance with their individual societal goals. Some initiatives may be undertaken by a single society, whereas other objectives and initiatives may be approached jointly. It is a 5-year plan that covers seven major domains:
- Clinical setting.
- Education.
- Research.
- Society efforts.
- Intersociety efforts.
- Industry.
- Advocacy.
The plan was developed by the U.S. Multi-GI Society Task Force on Climate Change, which is composed of leading experts from AASLD, ACG, AGA, and ASGE.
For more information, view the full publication: GI Multisociety Strategic Plan on Environmental Sustainability, published in Gastroenterology, Gastrointestinal Endoscopy, HEPATOLOGY, and The American Journal of Gastroenterology.
Key takeaway: As a procedure-intense subspecialty, gastroenterology, and in particular endoscopy, is a major contributor to health care’s carbon footprint and other environmental impacts. Endoscopy is the third largest generator of medical waste in a hospital (2 kg total waste per procedure) with most ending in landfills. With this strategic plan, the participating societies are committed to promoting and supporting a sustainable, high-quality GI practice.
The U.S. GI multisociety strategic plan, which has also been endorsed by 23 GI societies globally, is a collaborative effort that invites members to undertake initiatives to establish an environmentally sustainable, high-quality practice and promote planetary health. Each society will prioritize and adapt their initiatives in accordance with their individual societal goals. Some initiatives may be undertaken by a single society, whereas other objectives and initiatives may be approached jointly. It is a 5-year plan that covers seven major domains:
- Clinical setting.
- Education.
- Research.
- Society efforts.
- Intersociety efforts.
- Industry.
- Advocacy.
The plan was developed by the U.S. Multi-GI Society Task Force on Climate Change, which is composed of leading experts from AASLD, ACG, AGA, and ASGE.
For more information, view the full publication: GI Multisociety Strategic Plan on Environmental Sustainability, published in Gastroenterology, Gastrointestinal Endoscopy, HEPATOLOGY, and The American Journal of Gastroenterology.
Key takeaway: As a procedure-intense subspecialty, gastroenterology, and in particular endoscopy, is a major contributor to health care’s carbon footprint and other environmental impacts. Endoscopy is the third largest generator of medical waste in a hospital (2 kg total waste per procedure) with most ending in landfills. With this strategic plan, the participating societies are committed to promoting and supporting a sustainable, high-quality GI practice.
The U.S. GI multisociety strategic plan, which has also been endorsed by 23 GI societies globally, is a collaborative effort that invites members to undertake initiatives to establish an environmentally sustainable, high-quality practice and promote planetary health. Each society will prioritize and adapt their initiatives in accordance with their individual societal goals. Some initiatives may be undertaken by a single society, whereas other objectives and initiatives may be approached jointly. It is a 5-year plan that covers seven major domains:
- Clinical setting.
- Education.
- Research.
- Society efforts.
- Intersociety efforts.
- Industry.
- Advocacy.
The plan was developed by the U.S. Multi-GI Society Task Force on Climate Change, which is composed of leading experts from AASLD, ACG, AGA, and ASGE.
For more information, view the full publication: GI Multisociety Strategic Plan on Environmental Sustainability, published in Gastroenterology, Gastrointestinal Endoscopy, HEPATOLOGY, and The American Journal of Gastroenterology.
What to know about 2023 Medicare payments
The Centers for Medicare and Medicaid Services released its final rules for 2023 Medicare payments.
Good news! The full CRC continuum will be covered in Medicare.
In a win for patients and thanks to our collective advocacy efforts from AGA and partner societies, CMS expanded the regulatory definition of “colorectal cancer screening tests” and will waive cost sharing for a necessary follow-up colonoscopy after a positive stool-based screening test.
Bad news: Looming cuts on the horizon, GI societies to take action.
The rule finalizes more than 4% in mandated Medicare physician reimbursement cuts through decreases in the conversion factor and expiration of temporary fixes passed by Congress. The CY 2023 conversion factor is $33.06, an unacceptable cut for our members. The GI societies continue to work with a coalition of national and state medical societies to urge Congress to prevent these cuts before Jan. 1, 2023.
Good news: ASC + hospital payments on the rise.
ASC payments and facility fee payments increase 3.8% for institutions that meet quality reporting requirements. The CY 2023 ASC conversion factor is $51.854 and the hospital outpatient conversion factor is $85.585.
CMS removed motility codes 91117 and 91122 from APC 5731, where their payments would have been cut 21%, and finalized their placement in APC 5722, where they get a 3% payment increase beginning Jan. 1, 2023. Thank you to the motility community for helping us secure this win.
CMS raises the hospital payment for ESD code C9779 to $3,260.69, a $765.65 increase from 2022. We continue to work with CMS on our request for separate codes for lower ESD and upper ESD and payments that better reflect their unique resource costs.
The Centers for Medicare and Medicaid Services released its final rules for 2023 Medicare payments.
Good news! The full CRC continuum will be covered in Medicare.
In a win for patients and thanks to our collective advocacy efforts from AGA and partner societies, CMS expanded the regulatory definition of “colorectal cancer screening tests” and will waive cost sharing for a necessary follow-up colonoscopy after a positive stool-based screening test.
Bad news: Looming cuts on the horizon, GI societies to take action.
The rule finalizes more than 4% in mandated Medicare physician reimbursement cuts through decreases in the conversion factor and expiration of temporary fixes passed by Congress. The CY 2023 conversion factor is $33.06, an unacceptable cut for our members. The GI societies continue to work with a coalition of national and state medical societies to urge Congress to prevent these cuts before Jan. 1, 2023.
Good news: ASC + hospital payments on the rise.
ASC payments and facility fee payments increase 3.8% for institutions that meet quality reporting requirements. The CY 2023 ASC conversion factor is $51.854 and the hospital outpatient conversion factor is $85.585.
CMS removed motility codes 91117 and 91122 from APC 5731, where their payments would have been cut 21%, and finalized their placement in APC 5722, where they get a 3% payment increase beginning Jan. 1, 2023. Thank you to the motility community for helping us secure this win.
CMS raises the hospital payment for ESD code C9779 to $3,260.69, a $765.65 increase from 2022. We continue to work with CMS on our request for separate codes for lower ESD and upper ESD and payments that better reflect their unique resource costs.
The Centers for Medicare and Medicaid Services released its final rules for 2023 Medicare payments.
Good news! The full CRC continuum will be covered in Medicare.
In a win for patients and thanks to our collective advocacy efforts from AGA and partner societies, CMS expanded the regulatory definition of “colorectal cancer screening tests” and will waive cost sharing for a necessary follow-up colonoscopy after a positive stool-based screening test.
Bad news: Looming cuts on the horizon, GI societies to take action.
The rule finalizes more than 4% in mandated Medicare physician reimbursement cuts through decreases in the conversion factor and expiration of temporary fixes passed by Congress. The CY 2023 conversion factor is $33.06, an unacceptable cut for our members. The GI societies continue to work with a coalition of national and state medical societies to urge Congress to prevent these cuts before Jan. 1, 2023.
Good news: ASC + hospital payments on the rise.
ASC payments and facility fee payments increase 3.8% for institutions that meet quality reporting requirements. The CY 2023 ASC conversion factor is $51.854 and the hospital outpatient conversion factor is $85.585.
CMS removed motility codes 91117 and 91122 from APC 5731, where their payments would have been cut 21%, and finalized their placement in APC 5722, where they get a 3% payment increase beginning Jan. 1, 2023. Thank you to the motility community for helping us secure this win.
CMS raises the hospital payment for ESD code C9779 to $3,260.69, a $765.65 increase from 2022. We continue to work with CMS on our request for separate codes for lower ESD and upper ESD and payments that better reflect their unique resource costs.
New AGA guideline ranks the most effective drugs for weight loss
The following medications, paired with healthy eating and regular physical activity, are first-line medical options and result in moderate weight loss as noted as a percentage of body weight (reported as the difference compared to percent weight loss observed in the placebo group).
- Semaglutide (Wegovy®), weight loss percentage: 10.8%
- Phentermine-topiramate ER (Qsymia®), weight loss percentage: 8.5%
- Liraglutide (Saxenda®), weight loss percentage: 4.8%
- Naltrexone-bupropion ER (Contrave®), weight loss percentage: 3.0%
Read the AGA Clinical Guidelines on Pharmacological Interventions for Adults with Obesity for the complete recommendations.
The following medications, paired with healthy eating and regular physical activity, are first-line medical options and result in moderate weight loss as noted as a percentage of body weight (reported as the difference compared to percent weight loss observed in the placebo group).
- Semaglutide (Wegovy®), weight loss percentage: 10.8%
- Phentermine-topiramate ER (Qsymia®), weight loss percentage: 8.5%
- Liraglutide (Saxenda®), weight loss percentage: 4.8%
- Naltrexone-bupropion ER (Contrave®), weight loss percentage: 3.0%
Read the AGA Clinical Guidelines on Pharmacological Interventions for Adults with Obesity for the complete recommendations.
The following medications, paired with healthy eating and regular physical activity, are first-line medical options and result in moderate weight loss as noted as a percentage of body weight (reported as the difference compared to percent weight loss observed in the placebo group).
- Semaglutide (Wegovy®), weight loss percentage: 10.8%
- Phentermine-topiramate ER (Qsymia®), weight loss percentage: 8.5%
- Liraglutide (Saxenda®), weight loss percentage: 4.8%
- Naltrexone-bupropion ER (Contrave®), weight loss percentage: 3.0%
Read the AGA Clinical Guidelines on Pharmacological Interventions for Adults with Obesity for the complete recommendations.
An appeal from Michael Camilleri, MD, DSc, AGAF
This holiday season is a good time to reflect on our many blessings and thank those who have helped make our lives and careers worthwhile, successful, and prosperous. What better way than to pass on something to those who will ensure that gastroenterology will advance in decades to come?
Progress in this lifesaving work is made possible by the generosity of many supporters, like you, who understand the devastating physical, emotional, and financial costs of digestive diseases. We simply cannot allow a slowdown in the pace of GI research, and we cannot afford to lose talent when research offers so much promise for the future.
You can make a difference to ensure the progress continues.
The AGA Research Foundation funds promising young investigators who might not receive funding otherwise at crucial times in their early careers. The research of these talented individuals, while important to the field, if left unfunded, could end prematurely. That’s something the field can’t afford, and that’s why I’ve supported the AGA Research Foundation over the years through my donations.
We must maintain a robust pipeline of research that will help safeguard the success of clinical medicine. I urge you to support the future of GI with a generous donation to the AGA Research Foundation. Your investment of $100, $250, $500, $1,000, or any amount you can give today will make a difference.
Help close the gap in research funding and make a difference. Make your tax-deductible donation online at www.gastro.org/donateonline.
Thank you in advance for support and best wishes for a happy, healthy holiday season and prosperous New Year.
Three easy ways to give
Online: www.gastro.org/donateonline
Through the mail:
AGA Research Foundation
4930 Del Ray Avenue
Bethesda, MD 20814
Over the phone: 301-222-4002
Dr. Camilleri is chair of the AGA Research Foundation, past-president of the AGA Institute, and a consultant in the division of gastroenterology and hepatology, Mayo Clinic, Rochester, Minn.
This holiday season is a good time to reflect on our many blessings and thank those who have helped make our lives and careers worthwhile, successful, and prosperous. What better way than to pass on something to those who will ensure that gastroenterology will advance in decades to come?
Progress in this lifesaving work is made possible by the generosity of many supporters, like you, who understand the devastating physical, emotional, and financial costs of digestive diseases. We simply cannot allow a slowdown in the pace of GI research, and we cannot afford to lose talent when research offers so much promise for the future.
You can make a difference to ensure the progress continues.
The AGA Research Foundation funds promising young investigators who might not receive funding otherwise at crucial times in their early careers. The research of these talented individuals, while important to the field, if left unfunded, could end prematurely. That’s something the field can’t afford, and that’s why I’ve supported the AGA Research Foundation over the years through my donations.
We must maintain a robust pipeline of research that will help safeguard the success of clinical medicine. I urge you to support the future of GI with a generous donation to the AGA Research Foundation. Your investment of $100, $250, $500, $1,000, or any amount you can give today will make a difference.
Help close the gap in research funding and make a difference. Make your tax-deductible donation online at www.gastro.org/donateonline.
Thank you in advance for support and best wishes for a happy, healthy holiday season and prosperous New Year.
Three easy ways to give
Online: www.gastro.org/donateonline
Through the mail:
AGA Research Foundation
4930 Del Ray Avenue
Bethesda, MD 20814
Over the phone: 301-222-4002
Dr. Camilleri is chair of the AGA Research Foundation, past-president of the AGA Institute, and a consultant in the division of gastroenterology and hepatology, Mayo Clinic, Rochester, Minn.
This holiday season is a good time to reflect on our many blessings and thank those who have helped make our lives and careers worthwhile, successful, and prosperous. What better way than to pass on something to those who will ensure that gastroenterology will advance in decades to come?
Progress in this lifesaving work is made possible by the generosity of many supporters, like you, who understand the devastating physical, emotional, and financial costs of digestive diseases. We simply cannot allow a slowdown in the pace of GI research, and we cannot afford to lose talent when research offers so much promise for the future.
You can make a difference to ensure the progress continues.
The AGA Research Foundation funds promising young investigators who might not receive funding otherwise at crucial times in their early careers. The research of these talented individuals, while important to the field, if left unfunded, could end prematurely. That’s something the field can’t afford, and that’s why I’ve supported the AGA Research Foundation over the years through my donations.
We must maintain a robust pipeline of research that will help safeguard the success of clinical medicine. I urge you to support the future of GI with a generous donation to the AGA Research Foundation. Your investment of $100, $250, $500, $1,000, or any amount you can give today will make a difference.
Help close the gap in research funding and make a difference. Make your tax-deductible donation online at www.gastro.org/donateonline.
Thank you in advance for support and best wishes for a happy, healthy holiday season and prosperous New Year.
Three easy ways to give
Online: www.gastro.org/donateonline
Through the mail:
AGA Research Foundation
4930 Del Ray Avenue
Bethesda, MD 20814
Over the phone: 301-222-4002
Dr. Camilleri is chair of the AGA Research Foundation, past-president of the AGA Institute, and a consultant in the division of gastroenterology and hepatology, Mayo Clinic, Rochester, Minn.
AGA’s investment in the future of GI
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
Each year, the AGA Research Foundation provides research funding to transform the lives of talented investigators.
What will the practice of gastroenterology look like in 20 years? It is our hope that physicians have an abundance of new tools and treatments to care for their patients suffering from digestive disorders.
How will we get there? New treatments and devices are the result of years of research.
To help make this dream a reality, AGA – through the AGA Research Foundation – has made a commitment to support investigators in GI and hepatology with its Research Awards Program. In the past year, the AGA Research Foundation provided $2.5 million in research funding to 61 highly qualified investigators. These diverse researchers range from young investigators to more seasoned leaders in GI, all embarking on novel research projects that will advance our understanding of digestive conditions and pave the way for future discoveries in the field.
The AGA Research Foundation sincerely thanks all of its donors – without their contributions, this work wouldn’t be possible.
You can help spark the scientific breakthroughs of today so clinicians will have the tools to improve care tomorrow. Donate your tax-deductible gift today at www.gastro.org/donateonline.
New report: Physician views on race, ethnicity, and diversity in gastroenterology
The Intersociety Group on Diversity, in partnership with researchers at the University of California, Los Angeles, released results of the first study of its kind to explore perspectives on workforce diversity and health equity among practicing GI and hepatology professionals.
The report — Diversity, Equity, and Inclusion in GI and Hepatology: A Survey of Where We Stand — was published jointly in Gastroenterology, Gastrointestinal Endoscopy, HEPATOLOGY, and The American Journal of Gastroenterology. An executive summary is also available in the Journal of Pediatric Gastroenterology and Nutrition.
Key findings:
1. Many are complacent with current levels of diversity. Despite the well-recognized under-representation of certain racial and ethnic groups in GI/hepatology, a small proportion of survey participants (one-third or fewer) felt that racial/ethnic representation was insufficient in the educational/training pipeline, among practicing professionals, or in GI/hepatology leadership. There was a clear discrepancy in satisfaction with workplace diversity among GI and hepatology physicians by race and ethnicity: Overall, 63% of Black physicians were very or somewhat unsatisfied with workplace diversity, whereas 78% of White physicians were very or somewhat satisfied.
2. Interventions are needed. Among those who recommended interventions to enhance racial and gender diversity in the profession, the most common suggestions were to increase the following:
- Mentorship opportunities for resident and medical students who are women or from racial and ethnic populations underrepresented in medicine relative to their numbers in the general population. These groups have traditionally included Latino (i.e., Latino/a/x), Black/African American, Native American individuals (namely, American Indians, Alaska Natives, and Native Hawaiians), Pacific Islanders, and mainland Puerto Ricans.
- Representation of underrepresented in medicine GI/hepatology professionals in academic and professional society leadership.
More than 1,200 individuals participated in this nationwide, cross-sectional, 33-question survey. The survey was developed by University of California, Los Angeles investigators Folasade P. May, MD, PhD, MPhil; Harman Rahal, MD; James H. Tabibian, MD, PhD; and Liu Yang, PhD. The IGD, co-chaired at the time by Darrell M. Gray, II, MD, MPH, and Rachel Issaka, MD, MAS, provided input and facilitated survey distribution.
The Intersociety Group on Diversity, in partnership with researchers at the University of California, Los Angeles, released results of the first study of its kind to explore perspectives on workforce diversity and health equity among practicing GI and hepatology professionals.
The report — Diversity, Equity, and Inclusion in GI and Hepatology: A Survey of Where We Stand — was published jointly in Gastroenterology, Gastrointestinal Endoscopy, HEPATOLOGY, and The American Journal of Gastroenterology. An executive summary is also available in the Journal of Pediatric Gastroenterology and Nutrition.
Key findings:
1. Many are complacent with current levels of diversity. Despite the well-recognized under-representation of certain racial and ethnic groups in GI/hepatology, a small proportion of survey participants (one-third or fewer) felt that racial/ethnic representation was insufficient in the educational/training pipeline, among practicing professionals, or in GI/hepatology leadership. There was a clear discrepancy in satisfaction with workplace diversity among GI and hepatology physicians by race and ethnicity: Overall, 63% of Black physicians were very or somewhat unsatisfied with workplace diversity, whereas 78% of White physicians were very or somewhat satisfied.
2. Interventions are needed. Among those who recommended interventions to enhance racial and gender diversity in the profession, the most common suggestions were to increase the following:
- Mentorship opportunities for resident and medical students who are women or from racial and ethnic populations underrepresented in medicine relative to their numbers in the general population. These groups have traditionally included Latino (i.e., Latino/a/x), Black/African American, Native American individuals (namely, American Indians, Alaska Natives, and Native Hawaiians), Pacific Islanders, and mainland Puerto Ricans.
- Representation of underrepresented in medicine GI/hepatology professionals in academic and professional society leadership.
More than 1,200 individuals participated in this nationwide, cross-sectional, 33-question survey. The survey was developed by University of California, Los Angeles investigators Folasade P. May, MD, PhD, MPhil; Harman Rahal, MD; James H. Tabibian, MD, PhD; and Liu Yang, PhD. The IGD, co-chaired at the time by Darrell M. Gray, II, MD, MPH, and Rachel Issaka, MD, MAS, provided input and facilitated survey distribution.
The Intersociety Group on Diversity, in partnership with researchers at the University of California, Los Angeles, released results of the first study of its kind to explore perspectives on workforce diversity and health equity among practicing GI and hepatology professionals.
The report — Diversity, Equity, and Inclusion in GI and Hepatology: A Survey of Where We Stand — was published jointly in Gastroenterology, Gastrointestinal Endoscopy, HEPATOLOGY, and The American Journal of Gastroenterology. An executive summary is also available in the Journal of Pediatric Gastroenterology and Nutrition.
Key findings:
1. Many are complacent with current levels of diversity. Despite the well-recognized under-representation of certain racial and ethnic groups in GI/hepatology, a small proportion of survey participants (one-third or fewer) felt that racial/ethnic representation was insufficient in the educational/training pipeline, among practicing professionals, or in GI/hepatology leadership. There was a clear discrepancy in satisfaction with workplace diversity among GI and hepatology physicians by race and ethnicity: Overall, 63% of Black physicians were very or somewhat unsatisfied with workplace diversity, whereas 78% of White physicians were very or somewhat satisfied.
2. Interventions are needed. Among those who recommended interventions to enhance racial and gender diversity in the profession, the most common suggestions were to increase the following:
- Mentorship opportunities for resident and medical students who are women or from racial and ethnic populations underrepresented in medicine relative to their numbers in the general population. These groups have traditionally included Latino (i.e., Latino/a/x), Black/African American, Native American individuals (namely, American Indians, Alaska Natives, and Native Hawaiians), Pacific Islanders, and mainland Puerto Ricans.
- Representation of underrepresented in medicine GI/hepatology professionals in academic and professional society leadership.
More than 1,200 individuals participated in this nationwide, cross-sectional, 33-question survey. The survey was developed by University of California, Los Angeles investigators Folasade P. May, MD, PhD, MPhil; Harman Rahal, MD; James H. Tabibian, MD, PhD; and Liu Yang, PhD. The IGD, co-chaired at the time by Darrell M. Gray, II, MD, MPH, and Rachel Issaka, MD, MAS, provided input and facilitated survey distribution.
AGA President Dr. John Carethers named vice chancellor at UCSD
Everyone at AGA sends our congratulations to AGA President John Carethers, MD, AGAF, on his appointment as the vice chancellor for health sciences at the University of California San Diego.
Dr. Carethers, who began his term as the 117th president of the AGA Institute on June 1, 2022, is returning to UC San Diego after a 13-year tenure at the University of Michigan. He will report directly to the chancellor and serve as a part of the leadership team, effective Jan. 1, 2023.
Aside from his new role at UCSD, Dr. Carethers has been an active member of AGA for more than 20 years and has served on several AGA committees, including the AGA Nominating Committee, AGA Underrepresented Minorities Committee, AGA Research Policy Committee, AGA Institute Council and the AGA Trainee & Young GI Committee.
We wish him well in this new chapter!
Everyone at AGA sends our congratulations to AGA President John Carethers, MD, AGAF, on his appointment as the vice chancellor for health sciences at the University of California San Diego.
Dr. Carethers, who began his term as the 117th president of the AGA Institute on June 1, 2022, is returning to UC San Diego after a 13-year tenure at the University of Michigan. He will report directly to the chancellor and serve as a part of the leadership team, effective Jan. 1, 2023.
Aside from his new role at UCSD, Dr. Carethers has been an active member of AGA for more than 20 years and has served on several AGA committees, including the AGA Nominating Committee, AGA Underrepresented Minorities Committee, AGA Research Policy Committee, AGA Institute Council and the AGA Trainee & Young GI Committee.
We wish him well in this new chapter!
Everyone at AGA sends our congratulations to AGA President John Carethers, MD, AGAF, on his appointment as the vice chancellor for health sciences at the University of California San Diego.
Dr. Carethers, who began his term as the 117th president of the AGA Institute on June 1, 2022, is returning to UC San Diego after a 13-year tenure at the University of Michigan. He will report directly to the chancellor and serve as a part of the leadership team, effective Jan. 1, 2023.
Aside from his new role at UCSD, Dr. Carethers has been an active member of AGA for more than 20 years and has served on several AGA committees, including the AGA Nominating Committee, AGA Underrepresented Minorities Committee, AGA Research Policy Committee, AGA Institute Council and the AGA Trainee & Young GI Committee.
We wish him well in this new chapter!